Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancerLin, J.J. ; Liu, S.V. ; McCoach, C.E. ; Zhu, V.W. ; Tan, A.C. ; Yoda, S. ; Peterson, J. ; Do, A. ; Prutisto-Chang, K. ; Dagogo-Jack, I. ; Sequist, L.V. ; Wirth, L.J. ; Lennerz, J.K. ; Hata, A.N. ; Mino-Kenudson, M. ; Nardi, V. ; Ou, S.-H.I. ; Tan, D.S.-W. ; Gainor, J.F.Annals of oncology, 2020-12, Vol.31 (12), p.1725-1733 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertionsPiotrowska, Z. ; Costa, D.B. ; Oxnard, G.R. ; Huberman, M. ; Gainor, J.F. ; Lennes, I.T. ; Muzikansky, A. ; Shaw, A.T. ; Azzoli, C.G. ; Heist, R.S. ; Sequist, L.V.Annals of oncology, 2018-10, Vol.29 (10), p.2092-2097 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Acquired Resistance to Afatinib in EGFR-Mutant Lung CancerSequist, L.V ; Gerber, D.E ; Fidias, P ; Shaw, A.T ; Temel, J.S ; Heist, R.S ; Gainor, J.F ; Fulton, L ; Kennedy, E.A ; Muzikansky, A ; Engelma, J.AInternational journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S43-S44 [Periódico revisado por pares]Texto completo disponível |
|
4 |
Material Type: Artigo
|
Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant BiopsyPiotrowska, Z ; Niederst, M.J ; Mino-Kenudson, M ; Morales-Oyarvide, V ; Fulton, L ; Lockerman, E ; Howe, E ; Gainor, J.F ; Fidias, P ; Heist, R.S ; Shaw, A.T ; Engelman, J.A ; Sequist, L.VInternational journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S6-S7 [Periódico revisado por pares]Texto completo disponível |
|
5 |
Material Type: Artigo
|
Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and SurvivalMak, K.S ; Gainor, J.F ; Niemierko, A ; Oh, K.S ; Willers, H ; Choi, N.C ; Loeffler, J.S ; Sequist, L.V ; Shaw, A.T ; Shih, H.AInternational journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S51-S51 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expressionAguilar, E.J. ; Ricciuti, B. ; Gainor, J.F. ; Kehl, K.L. ; Kravets, S. ; Dahlberg, S. ; Nishino, M. ; Sholl, L.M. ; Adeni, A. ; Subegdjo, S. ; Khosrowjerdi, S. ; Peterson, R.M. ; Digumarthy, S. ; Liu, C. ; Sauter, J. ; Rizvi, H. ; Arbour, K.C. ; Carter, B.W. ; Heymach, J.V. ; Altan, M. ; Hellmann, M.D. ; Awad, M.M.Annals of oncology, 2019-10, Vol.30 (10), p.1653-1659 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical researchBelli, C. ; Penault-Llorca, F. ; Ladanyi, M. ; Normanno, N. ; Scoazec, J.-Y. ; Lacroix, L. ; Reis-Filho, J.S. ; Subbiah, V. ; Gainor, J.F. ; Endris, V. ; Repetto, M. ; Drilon, A. ; Scarpa, A. ; André, F. ; Douillard, J.-Y. ; Curigliano, G.Annals of oncology, 2021-03, Vol.32 (3), p.337-350 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
8 |
Material Type: Artigo
|
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumorsHellmann, M.D. ; Kim, T.-W. ; Lee, C.B. ; Goh, B.-C. ; Miller, W.H. ; Oh, D.-Y. ; Jamal, R. ; Chee, C.-E. ; Chow, L.Q.M. ; Gainor, J.F. ; Desai, J. ; Solomon, B.J. ; Das Thakur, M. ; Pitcher, B. ; Foster, P. ; Hernandez, G. ; Wongchenko, M.J. ; Cha, E. ; Bang, Y.-J. ; Siu, L.L. ; Bendell, J.Annals of oncology, 2019-07, Vol.30 (7), p.1134-1142 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
9 |
Material Type: Artigo
|
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50Gainor, J.F. ; Rizvi, H. ; Jimenez Aguilar, E. ; Skoulidis, F. ; Yeap, B.Y. ; Naidoo, J. ; Khosrowjerdi, S. ; Mooradian, M. ; Lydon, C. ; Illei, P. ; Zhang, J. ; Peterson, R. ; Ricciuti, B. ; Nishino, M. ; Zhang, J. ; Roth, J.A. ; Grishman, J. ; Anderson, D. ; Little, B.P. ; Carter, B.W. ; Arbour, K. ; Sauter, J.L. ; Mino-Kenudson, M. ; Heymach, J.V. ; Digumarthy, S. ; Shaw, A.T. ; Awad, M.M. ; Hellmann, M.D.Annals of oncology, 2020-03, Vol.31 (3), p.404-411 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trialGriesinger, F. ; Curigliano, G. ; Thomas, M. ; Subbiah, V. ; Baik, C.S. ; Tan, D.S.W. ; Lee, D.H. ; Misch, D. ; Garralda, E. ; Kim, D.-W. ; van der Wekken, A.J. ; Gainor, J.F. ; Paz-Ares, L. ; Liu, S.V. ; Kalemkerian, G.P. ; Houvras, Y. ; Bowles, D.W. ; Mansfield, A.S. ; Lin, J.J. ; Smoljanovic, V. ; Rahman, A. ; Kong, S. ; Zalutskaya, A. ; Louie-Gao, M. ; Boral, A.L. ; Mazières, J.Annals of oncology, 2022-11, Vol.33 (11), p.1168-1178 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |